Touchstone International Medical Science Co., Ltd. (SHA:688013)

SHA:688013 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	295.8	272.34	253.6	231.73	213.74	163.34
Other Revenue	0	0.03	0.04	0.31	0	0
Revenue	295.8	272.37	253.65	232.03	213.74	163.34
Revenue Growth (YoY)	14.26%	7.38%	9.31%	8.56%	30.85%	-5.45%
Cost of Revenue	115.84	113.64	111.8	99.8	91.27	68.25
Gross Profit	179.96	158.73	141.85	132.23	122.47	95.09
Selling, General & Admin	80.97	74.66	71.9	61.66	62.37	48.47
Research & Development	39.32	35.99	35.32	34.75	29.28	15.37
Other Operating Expenses	2.01	1.79	4.75	2.39	2.13	1.35
Operating Expenses	122.62	112.38	112.27	98.97	94.05	65.27
Operating Income	57.34	46.34	29.58	33.27	28.41	29.82
Interest Expense	-0.32	-0.23	-0.09	-0.16	-	-
Interest & Investment Income	7.63	9.12	8.03	4.76	11.15	2.26
Currency Exchange Gain (Loss)	11.93	-0.01	2.47	3.94	4	1.8
Other Non Operating Income (Expenses)	-0.25	-0.17	1.89	-0.12	-0.06	-0.09
EBT Excluding Unusual Items	76.33	55.06	41.88	41.69	43.51	33.79
Gain (Loss) on Sale of Investments	-1.79	-1.89	4.06	2.09	0.44	0.56
Gain (Loss) on Sale of Assets	-0.01	-0	0	0.02	0.52	-0
Legal Settlements	-	-	-	-	-1.08	-
Other Unusual Items	2.27	1.66	2.01	2.28	2.71	5.85
Pretax Income	76.8	54.83	47.95	46.08	46.09	40.2
Income Tax Expense	5.54	2.94	0.64	2.89	4.67	5.25
Net Income	71.26	51.89	47.31	43.2	41.42	34.95
Net Income to Common	71.26	51.89	47.31	43.2	41.42	34.95
Net Income Growth	43.74%	9.69%	9.53%	4.29%	18.52%	-16.80%
Shares Outstanding (Basic)	80	80	79	80	80	65
Shares Outstanding (Diluted)	82	81	82	82	81	65
Shares Change (YoY)	0.64%	-0.60%	0.09%	0.35%	25.49%	7.85%
EPS (Basic)	0.89	0.65	0.60	0.54	0.52	0.54
EPS (Diluted)	0.87	0.64	0.58	0.53	0.51	0.54
EPS Growth	42.83%	10.35%	9.43%	3.92%	-5.56%	-22.86%
Free Cash Flow	10.49	11.47	64.54	2.73	51.77	34.79
Free Cash Flow Per Share	0.13	0.14	0.79	0.03	0.64	0.54
Dividend Per Share	1.000	1.000	-	0.250	0.200	0.200
Dividend Growth	100.00%	-	-	25.00%	-	-
Gross Margin	60.84%	58.28%	55.92%	56.99%	57.30%	58.22%
Operating Margin	19.39%	17.02%	11.66%	14.34%	13.29%	18.25%
Profit Margin	24.09%	19.05%	18.65%	18.62%	19.38%	21.39%
Free Cash Flow Margin	3.55%	4.21%	25.44%	1.18%	24.22%	21.30%
EBITDA	66.9	55.53	38.63	41.35	35.64	36.36
EBITDA Margin	22.62%	20.39%	15.23%	17.82%	16.67%	22.26%
D&A For EBITDA	9.56	9.19	9.05	8.09	7.22	6.54
EBIT	57.34	46.34	29.58	33.27	28.41	29.82
EBIT Margin	19.39%	17.02%	11.66%	14.34%	13.29%	18.25%
Effective Tax Rate	7.22%	5.36%	1.33%	6.27%	10.14%	13.07%
Revenue as Reported	295.8	272.37	253.65	232.03	213.74	163.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.